Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia

Author:

Hayakawa Kayoko,Marchaim Dror,Martin Emily T.,Tiwari Namita,Yousuf Adnan,Sunkara Bharath,Pulluru Harish,Kotra Harikrishna,Hasan Asma,Bheemreddy Suchitha,Sheth Puja,Lee Dae-Won,Kamatam Srinivasa,Bathina Pradeep,Nanjireddy Priyanka,Chalana Indu K.,Patel Satyam,Kumar Sarwan,Vahia Amit,Ku Kimberly,Yee Victoria,Swan Jessie,Pogue Jason M.,Lephart Paul R.,Rybak Michael J.,Kaye Keith S.

Abstract

ABSTRACTIn published studies, cohorts of patients with bacteremia due to vancomycin-resistantEnterococcus(VRE) have predominantly been infected withEnterococcus faecium. Little is known about the epidemiology and outcomes associated with bacteremia due to VREnterococcus faecalis. A retrospective study of isolates obtained from January 2008 to October 2010 was conducted at Detroit Medical Center (DMC). Unique patients with blood cultures positive for VRE were reviewed. Outcomes were analyzed using logistic regression. During the study period, 105 cases of bacteremia due to VRE. faecalisand 197 cases of bacteremia due to VRE. faeciumwere identified. The mean age in the study cohort was 61.5 ± 15 years; 162 subjects (53.6%) were male. After controlling for a propensity score, bacteremia due to VRE. faecaliswas associated with >2-fold-lower in-hospital mortality than bacteremia due to VRE. faecium. Interestingly, bacteremia due to VRE. faecaliswas associated with longer hospital stay after VRE isolation, although total length of stay was similar for groups with VRE. faecalisand VRE. faecium. Bacteremia due to VRE. faecaliswas associated with a >2-fold-lower risk for mortality than bacteremia due to VRE. faecium, possibly due to the availability of β-lactam therapeutics for treatment of VRE. faecalis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference28 articles.

1. Management of multidrug-resistant enterococcal infections;Arias;Clin. Microbiol. Infect.,2010

2. Validation of a prognostic score in critically ill patients undergoing transport;Bion;Br. Med. J. (Clin. Res. Ed.),1985

3. Health and economic outcomes of vancomycin-resistant enterococci;Carmeli;Arch. Intern. Med.,2002

4. Centers for Disease Control and Prevention. 2011. Central line-associated bloodstream infection (CLABSI) event. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Centers for Disease Control and Prevention, Atlanta, GA.

5. Vancomycin-resistant enterococci;Cetinkaya;Clin. Microbiol. Rev.,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3